Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder
1 other identifier
observational
100
1 country
1
Brief Summary
The goal of this observational study is to learn about The immune cell landscape of peripheral blood mononuclear cells in children with ADHD compared to typically developing controls. The main question it aims to answer are: 1.Testing the differences in immune cell subpopulations, protein expression and signaling pathways and cell subsets between two groups 2. Exploring the correlations between immune function in PBMC and resting-state brain functional networks in children with ADHD. Participants will be taken peripheral blood about 5 ml , cognitive assessment including Intelligence testing, Stroop color-word test and Trail making test, clinical interview and brain structural and functional MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2023
CompletedFirst Posted
Study publicly available on registry
October 31, 2023
CompletedStudy Start
First participant enrolled
December 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
April 1, 2025
January 1, 2025
3.4 years
October 22, 2023
March 27, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
the differences in immune cell subpopulations, protein expression , signaling pathways between ADHD and typically developing children
Blood samples of ADHD patients and normal control groups were collected, peripheral blood mononuclear cells were extracted, and 41 protein markers on cell surface were detected and analyzed by CyTOF technology, and detailed atlas of ADHD immune cells were drawn for immunological index analysis. These indicators include cytokine levels, immune cell subsets, and immune-related gene expression.
2023.11.1-2023.12.31 Participant recruitment and deta collections
Clinical assessment and cognitive function testing
The Clinical Diagnostic Interview Scale (CDIS) was used to evaluate ADHD types, comorbidities, types, comorbidities and clinical symptoms by child psychiatrists with the title of attending psychiatrist or above. ADHD-RS symptom assessment questionnaire was used to assess the severity of symptoms. Cognitive function tests include child IQ, Stroop color word naming test, and Trail making test (TMT).
2023.11.1-2023.12.31 Participant recruitment and deta collections
Brain MRI structure and resting state data
High-resolution brain structure images were acquired using 3D Magnetization Prepared Rapid Acquisition Gradient-echo (MPRAGE). The FMRI images were acquired by spin-echo-echo planar imaging (SE-EPI)
2023.11.1-2023.12.31 Participant recruitment and deta collections
Secondary Outcomes (1)
General and demographic data collection
2023.11.1-2023.12.31 data collection
Study Arms (2)
ADHD children
Take peripheral blood 5ml; IQ and cognitive function test; Head MRI scan
typically developing controls
Take peripheral blood 5ml; IQ and cognitive function test; Head MRI scan
Interventions
Participants will be taken peripheral blood about 5 ml
Eligibility Criteria
Children and teenagers ages 6-12 years
You may qualify if:
- Clinical diagnosis of ADHD; Children with an IQ≥70; Both parents are Han; Agree to take venous blood with informed consent;
You may not qualify if:
- Schizophrenia, mood disorder, autism, mental retardation; Obvious physical and nervous system abnormalities;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fu Guanghui
Hangzhou, Zhejiang, 310000, China
Related Publications (2)
Ni Chasaide C, Lynch MA. The role of the immune system in driving neuroinflammation. Brain Neurosci Adv. 2020 Jan 29;4:2398212819901082. doi: 10.1177/2398212819901082. eCollection 2020 Jan-Dec.
PMID: 32219178RESULTDarwish AH, Elgohary TM, Nosair NA. Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD). J Child Neurol. 2019 Feb;34(2):61-67. doi: 10.1177/0883073818809831. Epub 2018 Nov 15.
PMID: 30430896RESULT
Biospecimen
Peripheral blood monocyte
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hu Guanghui, doctor
Department of Psychiatry, the First Affiliated Hospital, Zhejiang University School of Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2023
First Posted
October 31, 2023
Study Start
December 4, 2023
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
April 1, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share